Could oxidative stress be the hidden key to IVF success?
NCT ID NCT06831019
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how oxidative stress—a type of cell damage—in both women and men affects the success of in vitro fertilization (IVF). Researchers will measure oxidative stress markers in blood, egg follicle fluid, and sperm from 1,100 couples. The goal is to see if higher oxidative stress is linked to poorer embryo development and lower pregnancy rates.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors understand how oxidative stress affects fertility and improve IVF success rates.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve outcomes for participants and may not lead to clear clinical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Heterosexual couples undergoing fresh IVF cycle
- Ages
-
18 to 43 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Female age 18-43 years 2. Subjects planning blastocyst culture for preimplantation genetic screening (PGS) for aneuploidy. 3. Male partners 18 years of age or older. 4. Must be a registered patient at UCSF Center for Reproductive Health 5. Patient and partner must both be physically present on the day of retreival Exclusion Criteria: 1. Female partner age 44 or older 2. Planning fresh transfer (hybrid PGS cycle) 3. Cleavage stage biopsy 4. Planning to use frozen sperm
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ivf outcome are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94158, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a berry extract help athletes bounce back after brutal workouts?
- Herbal extract may turn gym sessions into stress relief and brain boost
- Can Antioxidant-Rich foods counteract air Pollution's harmful effects?
- Could a simple blood test flag heart risk in rheumatoid arthritis?
- Could a mushroom compound turn back the clock on aging?
- Could a daily cocoa drink help keep blood vessels young?